BAP1 germline variants in Finnish patients with malignant mesothelioma

被引:6
|
作者
Repo, Pauliina [1 ,2 ,3 ]
Staskiewicz, Aleksandra [1 ,2 ,3 ]
Sutinen, Eva [4 ,5 ]
Ronty, Mikko [6 ,7 ]
Kivela, Tero T. [2 ,3 ]
Myllarniemi, Marjukka [4 ,5 ]
Turunen, Joni A. [1 ,2 ,3 ]
机构
[1] Folkhalsan Res Ctr, Eye Genet Grp, Helsinki, Finland
[2] Helsinki Univ Hosp, Dept Ophthalmol, Helsinki, Finland
[3] Univ Helsinki, Helsinki, Finland
[4] Helsinki Univ Hosp, Heart & Lung Ctr, Dept Pulm Med, Helsinki, Finland
[5] Univ Helsinki, Fac Med, Individualized Drug Therapy Res Program, Helsinki, Finland
[6] Univ Helsinki, HUS Diagnost Ctr, Dept Pathol, HUSLAB, Helsinki, Finland
[7] Helsinki Univ Hosp, Helsinki, Finland
关键词
Malignant mesothelioma; BAP1; Tumor predisposition; BAP1-TPDS; BAP1-inactivated nevus; MUTATIONS; ASBESTOS;
D O I
10.1016/j.lungcan.2022.01.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Although asbestos exposure is the most common cause of malignant mesothelioma (MM), an aggressive cancer of the pleura or peritoneum, up to 7% of patients harbor a genetic predisposition to MM. Pathogenic germline variants in the BRCA1-associated protein 1 (BAP1) gene cause a dominantly inherited tumor predisposition syndrome, BAP1-TPDS, in which MM is the second most common associated cancer. Other frequent cancers in BAP1-TPDS are uveal melanoma (UM), cutaneous melanoma and renal cell carcinoma. Additionally patients can exhibit benign skin lesions, BAP1-inactivated nevi (BIN). Most BINs arise sporadically, but patients with BAP1-TPDS may harbor multiple BINs before other tumors or as the only indication of the syndrome. Our objective was to establish the frequency of pathogenic germline BAP1 variants in Finnish patients with MM. Materials and methods: 56 DNA samples archived in the Helsinki Biobank from Finnish patients with MM were sequenced for germline BAP1 variations. Formalin fixed paraffin embedded nevi from a pathogenic variant carrier were subjected to immunohistochemistry and exome sequencing. Results: Sanger sequencing identified one patient with Finnish founder mutation c.1780_1781insT, p. (G549Vfs*49) in BAP1. The carrier was diagnosed with MM over fifteen years before the cohorts mean onset age (mean 68, range 27 to 82) although the patient had no asbestos exposure or family history of BAP1-TPDS. However, the patient had three BINs removed prior to the MM. The c.1780_1781insT is now found from five Finnish BAP1-TPDS families with unknown common ancestor. Conclusion: The frequency of pathogenic germline BAP1 variants in Finnish patients with MM is 1.8 % (95 % CI, 0.04 to 9.2), comparable to the frequency in Finnish patients with UM (1.9 %). The frequency of recurring BINs in patients with BAP1-TPDS should be studied further and genetic testing for BAP1 variants considered if the patient has >= 2 BAP1-TPDS core tumors, including BINs.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 50 条
  • [21] Prevalence of BAP1 germline mutations in asbestos-exposed malignant mesothelioma cases and controls
    Cheung, Mitchell
    Talarchek, Jacqueline
    Howard, Suzanne E.
    Howard, Timothy
    Peng, Hongzhuang
    Hesdorffer, Mary
    Rauscher, Frank J.
    Ohar, Jill A.
    Testa, Joseph
    CANCER RESEARCH, 2015, 75
  • [22] BAP1 in advanced sporadic malignant pleural mesothelioma
    El Bastawisy, A.
    Shehab, R.
    Bahnassy, A.
    Sabri, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] BAP1 expression and treatment outcomes in malignant mesothelioma
    Kumar, Neelam
    Kolluri, Krishna
    Sage, Elizabeth
    Borg, Elaine
    Falzon, Mary
    Nicholson, Andrew
    Janes, Sam
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
    Carbone, Michele
    Pass, Harvey, I
    Ak, Guntulu
    Alexander, H. Richard
    Baas, Paul
    Baumann, Francine
    Blakely, Andrew M.
    Bueno, Raphael
    Bzura, Aleksandra
    Cardillo, Giuseppe
    Churpek, Jane E.
    Dianzani, Irma
    De Rienzo, Assunta
    Emi, Mitsuru
    Emri, Salih
    Felley-Bosco, Emanuela
    Fennell, Dean A.
    Flores, Raja M.
    Grosso, Federica
    Hayward, Nicholas K.
    Hesdorffer, Mary
    Hoang, Chuong D.
    Johansson, Peter A.
    Kindler, Hedy L.
    Kittaneh, Muaiad
    Krausz, Thomas
    Mansfield, Aaron
    Metintas, Muzaffer
    Minaai, Michael
    Mutti, Luciano
    Nielsen, Maartje
    O'Byrne, Kenneth
    Opitz, Isabelle
    Pastorino, Sandra
    Pentimalli, Francesca
    de Perrot, Marc
    Pritchard, Antonia
    Ripley, Robert Taylor
    Robinson, Bruce
    Rusch, Valerie
    Taioli, Emanuela
    Takinishi, Yasutaka
    Tanji, Mika
    Tsao, Anne S.
    Tuncer, A. Murat
    Walpole, Sebastian
    Wolf, Andrea
    Yang, Haining
    Yoshikawa, Yoshie
    Zolondick, Alicia
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (07) : 873 - 889
  • [25] BAP1 mutation in mesothelioma and "BAP1 Cancer Syndrome"
    Nasu, Masaki
    Napolitano, Andrea
    Pastorino, Sandra
    Tanji, Mika
    Flores, Erin
    Baumann, Francine
    Powers, Amy
    Gaudino, Giovanni
    Pass, Harvey I.
    Yang, Haining
    Carbone, Michele
    CANCER RESEARCH, 2014, 74 (19)
  • [26] BAP1 loss of protein expression: an analysis for BAP1 germline Variants of Unknown Signification (VUS) interpretation
    Cabaret, O.
    Caillot, C.
    Fenouil, T.
    Soufir, N.
    Bressac-de Paillerets, B.
    de la Fouchardiere, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1538 - 1538
  • [27] BAP1 Protein is a Progression Factor in Malignant Pleural Mesothelioma
    Arzt, Lisa
    Quehenberger, Franz
    Halbwedl, Iris
    Mairinger, Thomas
    Popper, Helmut H.
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (01) : 145 - 151
  • [28] Malignant Peritoneal Mesothelioma in an Adolescent Male With BAP1 Deletion
    Taylor, Steve
    Carpentieri, David
    Williams, James
    Acosta, Juan
    Southard, Richard
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (05) : e323 - e327
  • [29] BAP1, a tumor suppressor gene driving malignant mesothelioma
    Cheung, Mitchell
    Testa, Joseph R.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (03) : 270 - 278
  • [30] BAP1 loss in the diagnosis of malignant mesothelioma; review of a regional mesothelioma MDT
    Mcdill, H.
    Dipper, A.
    Bhatt, N.
    Clive, A.
    Maskell, N.
    Bibby, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60